Ajanta Pharma informs about update on board meeting

25 Jan 2024 Evaluate
With reference to its letter dated 19th January 2024, informing about the Board meeting scheduled on Wednesday, 31st January 2024 to consider and take on record the unaudited financial results for the third quarter ended 31st December 2023. Pursuant to Regulation 29(1)(e) of the Listing Regulations, Ajanta Pharma has informed that at the aforesaid Board Meeting, the Board of Directors will also consider: declaration of 2nd interim dividend for the financial year ending 31st March 2024 and fixation of Thursday, 8th Dec 2024 as the Record Date for the payment of 2nd interim dividend, if declared.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×